DrugPatentWatch Database Preview
Shire Company Profile
» See Plans and Pricing
What is the competitive landscape for SHIRE, and what generic and branded alternatives to SHIRE drugs are available?
SHIRE has twenty-five approved drugs.
Summary for Shire
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 16 |
| NDAs: | 25 |
| Patent Litigation for Shire: | See patent lawsuits for Shire |
| PTAB Cases with Shire as patent owner: | See PTAB cases with Shire as patent owner |
Drugs and US Patents for Shire
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-003 | Dec 24, 1991 | DISCN | No | No | Start Trial | Start Trial | |||||
| Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Shire Llc | SALURON | hydroflumethiazide | TABLET;ORAL | 011949-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Shire | BANTHINE | methantheline bromide | TABLET;ORAL | 007390-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Shire Richwood | X-TROZINE L.A. | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087371-001 | Aug 24, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Shire | FUROXONE | furazolidone | SUSPENSION;ORAL | 011323-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shire
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-003 | Jun 19, 1990 | 3,740,395 | Start Trial |
| Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-001 | Dec 24, 1991 | 4,244,946 | Start Trial |
| Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-001 | Jun 19, 1990 | 3,740,395 | Start Trial |
| Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-002 | Jun 19, 1990 | 3,740,395 | Start Trial |
| Shire | SUPPRELIN | histrelin acetate | INJECTABLE;INJECTION | 019836-002 | Dec 24, 1991 | 4,244,946 | Start Trial |
| Shire Orphan Therap | FIRAZYR | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 022150-001 | Aug 25, 2011 | 5,648,333 | Start Trial |
| Shire | ETHMOZINE | moricizine hydrochloride | TABLET;ORAL | 019753-003 | Jun 19, 1990 | 3,864,487 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SHIRE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 10 mg/mL | ➤ Subscribe | 2015-08-25 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
